Orchid Pharma Ltd
NSE: ORCHPHARMA BSE: 524372
₹699
(2.71)%
Mon, 09 Feb 2026, 06:18 am
Market Cap34.55B
PE Ratio67.84
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KFinancials
| Particulars | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.84B | 9.01B | 9.64B | 12.53B | 12.60B | 12.99B | 16.80B | 17.44B | 12.60B | 11.33B | 8.59B | 7.97B | 6.83B | 6.00B | 4.84B | 4.50B | 5.60B | 6.66B | 8.19B | 9.19B |
| Gross profit | 643.98M | 1.50B | 1.82B | 4.33B | 3.25B | -21.07M | 3.53B | 3.20B | 904.06M | 1.18B | 1.09B | 786.60M | 147.30M | 247.80M | -10.29M | -180.39M | 166.99M | 706.90M | 1.36B | 1.47B |
| Operating expenses (excl. COGS) | -85.47M | -515.94M | -1.78B | -2.35B | -2.91B | -2.92B | -2.44B | -2.14B | -2.16B | -1.37B | -972.09M | -1.88B | -1.04B | -984.37M | -690.75M | -316.63M | -491.44M | -410.20M | -584.47M | -658.14M |
| Selling/general/admin expenses, total | 0 | — | -1.75B | -2.32B | -3.06B | -2.90B | -2.39B | -2.39B | -2.12B | -1.31B | -958.97M | -1.85B | -958.81M | -959.32M | -610.82M | -379.41M | -483.03M | -400.38M | -564.17M | -642.76M |
| Research & development | 0 | -365.62M | -441.76M | -487.75M | -464.78M | -538.85M | -338.89M | -693.29M | -580.33M | -401.04M | -316.51M | -376.01M | -177.33M | -139.62M | -119.28M | -48.10M | -66.26M | -63.62M | -70.94M | -83.67M |
| Selling/general/admin expenses, other | — | — | -1.31B | -1.83B | -2.59B | -2.36B | -2.05B | -1.69B | -1.54B | -908.60M | -642.46M | -1.47B | -781.48M | -819.70M | -491.54M | -331.31M | -416.77M | -336.76M | -493.23M | -559.09M |
| Other operating expenses, total | -85.47M | -515.94M | -26.24M | -31.22M | 148.85M | -21.05M | -51.13M | 246.78M | -39.22M | -59.80M | -13.12M | -31.22M | -83.54M | -25.05M | -79.93M | 62.77M | -8.41M | -9.82M | -20.31M | -15.38M |
| Operating income | 558.50M | 988.52M | 1.82B | 1.98B | 344.88M | -2.94B | 1.09B | 1.06B | -1.25B | -184.98M | 115.82M | -1.09B | -895.05M | -736.56M | -701.04M | -497.03M | -324.46M | 296.69M | 777.04M | 811.13M |
| Non-operating income, total | -358.61M | -356.52M | -889.97M | 290.37M | -699.77M | 7.64B | 614.24M | -1.11B | -2.43B | -2.03B | -3.08B | -4.34B | -3.09B | 1.43B | 4.12M | -455.46M | -244.53M | 255.78M | 142.41M | 144.51M |
| Interest expense, net of interest capitalized | -735.46M | -878.45M | -992.91M | -824.60M | -1.58B | -2.44B | -1.22B | -1.80B | -3.48B | -3.58B | -2.94B | -3.47B | -3.10B | -66.88M | -62.30M | -522.06M | -334.56M | -329.02M | -167.36M | -149.34M |
| Interest capitalized | 109.07M | 158.53M | 258.17M | 397.91M | 454.12M | 466.23M | 509.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 376.84M | 521.93M | 102.94M | 1.11B | 203.30M | 10.08B | 1.84B | 1.51B | 1.63B | 418.99M | 388.45M | -14.34M | 7.99M | -511.76M | 66.42M | 66.60M | 90.03M | 584.80M | 309.76M | 293.86M |
| Non-operating interest income | 2.40M | 1.08M | 0 | 4.59M | 11.62M | 17.29M | 56.01M | 0 | 0 | 0 | 0 | 147.96M | 115.13M | 150.85M | 241.75M | 7.33M | 4.19M | 6.18M | 163.48M | 169.78M |
| Miscellaneous non-operating expense | 374.44M | 520.85M | 102.94M | 1.11B | 191.68M | 10.06B | 1.78B | 1.51B | 1.63B | 418.99M | 388.45M | -162.30M | -107.14M | -662.61M | -175.33M | 59.28M | 85.84M | 578.62M | 146.28M | 124.08M |
| Unusual income/expense | — | — | — | — | 673.05M | — | — | -820.01M | -573.83M | 1.13B | -525.45M | -862.59M | — | 2.01B | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax income | 199.89M | 632.00M | 925.57M | 2.27B | -354.89M | 4.70B | 1.70B | -45.64M | -3.68B | -2.21B | -2.96B | -5.44B | -3.99B | 694.08M | -696.92M | -952.49M | -568.99M | 552.47M | 919.45M | 955.65M |
| Taxes | 21.03M | -59.00M | -140.08M | -516.35M | -135.01M | -1.31B | -141.51M | 220.42M | 83.48M | 1.28B | 172.51M | 483.42M | 461.94M | 0 | 0 | 0 | 0 | 0 | 31.19M | 1.94M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.10M | 4.12M | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 220.87M | 573.00M | 785.49M | 1.75B | -489.90M | 3.39B | 1.56B | 174.78M | -3.59B | -933.73M | -2.79B | -4.95B | -3.53B | 694.08M | -696.92M | -952.49M | -604.21M | 530.93M | 921.66M | 996.57M |
| Net income | 220.87M | 573.00M | 785.49M | 1.75B | -489.90M | 3.39B | 1.56B | 174.78M | -3.59B | -933.73M | -2.79B | -4.95B | -3.53B | 694.08M | -1.31B | -1.17B | -19.51M | 463.18M | 921.66M | 996.57M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 220.87M | 573.00M | 785.49M | 1.75B | -489.90M | 3.39B | 1.56B | 174.78M | -3.59B | -933.73M | -2.79B | -4.95B | -3.53B | 694.08M | -1.31B | -1.17B | -19.51M | 463.18M | 921.66M | 996.57M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 1.10B | 1.85B | 2.67B | 2.99B | 1.68B | -1.39B | 2.42B | 2.60B | 427.90M | 1.98B | 1.57B | 317.37M | 438.08M | 562.87M | 478.24M | 592.14M | 545.79M | 844.56M | 1.11B | 1.16B |
| EBIT | 558.50M | 988.52M | 1.82B | 1.98B | 344.88M | -2.94B | 1.09B | 1.06B | -1.25B | -184.98M | 115.82M | -1.09B | -895.05M | -736.56M | -701.04M | -497.03M | -324.46M | 296.69M | 777.04M | 811.13M |
| Total operating expenses | -6.28B | -8.02B | -7.82B | -10.55B | -12.26B | -15.93B | -15.71B | -16.38B | -13.85B | -11.51B | -8.48B | -9.06B | -7.72B | -6.74B | -5.54B | -5.00B | -5.92B | -6.36B | -7.41B | -8.38B |
| Prepaid expenses | 71.58M | 86.35M | 91.83M | 398.73M | 410.09M | 1.07B | 1.68B | 1.01B | 149.74M | 14.19M | 123.40M | 100.85M | 178.54M | 96.35M | 126.83M | 25.66M | 71.18M | 37.91M | 22.18M | 22.77M |
| Deferred income, current | — | — | — | — | — | — | — | — | 1.64M | — | — | 195.99M | 26.08M | 108.32M | 14.67M | 374.00K | 87.89M | 16.76M | 19.47M | 44.53M |
| Capital and operating lease obligations | 10.51M | 9.41M | 18.61M | 18.61M | 15.39M | 8.89M | 2.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.70M | 367.00K |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | 800.60M | 923.60M | 1.15B | 1.28B | 2.03B | 1.94B | 1.70B | 2.12B | 1.11B | 941.42M | 494.20M | 32.26M | 973.68M | 2.01B | 1.53B | 860.61M | 893.32M | 1.11B | — |
| Deferred income, non-current | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — |
| Minority interest | 12.00K | 0 | 0 | 0 | 0 | 0 | 19.23M | 28.23M | 6.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -146.12M | -155.68M | -225.13M | -231.05M | -230.63M | -82.41M | -818.01M | -249.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800